Daewon Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was KRW 34.15 million compared to KRW 3.55 million a year ago. Net income was KRW 10,505.25 million compared to net loss of KRW 8,080.62 million a year ago. Basic earnings per share from continuing operations was KRW 495 compared to basic loss per share from continuing operations of KRW 381 a year ago. Basic earnings per share was KRW 495 compared to basic loss per share of KRW 381 a year ago.